scienze della vita roma, 22-23 ottobre 2012 - SIF

[8] P. Arrigo, N. Maggi, and C. Ruggiero, "In silico screening of Rac1 ligand specificity," in
Engineering in Medicine and Biology Society, 2008. EMBS 2008. 30th Annual International
Conference of the IEEE, 2008, pp. 4098-4101.
[9] N. Maggi, P. Arrigo, and C. Ruggiero, "SNP analysis of Rac1 For personalized ligand
interaction," in Engineering in Medicine and Biology Society (EMBC), 2010 Annual
International Conference of the IEEE, 2010, pp. 1779-1782.
[10] N. Maggi, P. Arrigo, and C. Ruggiero, "Drug design for cardiovascular disease: The effect
of solvation energy on Rac1-ligand interactions," in Engineering in Medicine and Biology
Society,EMBC, 2011 Annual International Conference of the IEEE, 2011, pp. 3237-3240.
[11] N. Maggi, P. Arrigo, and C. Ruggiero, "Comparative Analysis of Rac1 Binding Efficiency
With Different Classes of Ligands: Morpholines, Flavonoids and Imidazoles,"
NanoBioscience, IEEE Transactions on, vol. 11, pp. 181-187, 2012.
[12] L. Pastorino, S. Erokhina, F. C. Soumetz, P. Bianchini, O. Konovalov, A. Diaspro, C.
Ruggiero, and V. Erokhin, "Collagen containing microcapsules: Smart containers for disease
controlled therapy," Journal of Colloid and Interface Science, vol. 357, pp. 56-62, 2011.
[13] L. Pastorino, F. C. Soumetz, and C. Ruggiero, "Nanostructured thin films for the
development of piezoelectric immunosensors," Conf Proc IEEE Eng Med Biol Soc, vol.
2007, pp. 2257-60, 2007.
[14] R. A. Petros and J. M. DeSimone, "Strategies in the design of nanoparticles for therapeutic
applications," Nat Rev Drug Discov, vol. 9, pp. 615-627, 2010.
[15] U. Boas and P. M. H. Heegaard, "Dendrimers in drug research," Chemical Society Reviews,
vol. 33, pp. 43-63, 2004.
[16] N. Maggi, P. Arrigo, and C. Ruggiero, "In silico evaluation of nanoparticle cell interaction
via human TLR3," in Nanotechnology (IEEE-NANO), 2010 10th IEEE Conference on,
2010, pp. 995-998.
28